Geena Richards
Physician Assistant · Monaca, PANPI 1700538477
Payments from drug & device makers
Across 321 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$743
- Vanda Pharmaceuticals Inc.$525
- Johnson & Johnson$366
- plus $1K from 13 others
What the payments were for
- Food & beverage$7,761100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 126 | $2,739 |
| Alkermes, Inc. | 35 | $1,049 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $1,021 |
| Otsuka America Pharmaceutical, Inc. | 23 | $743 |
| Vanda Pharmaceuticals Inc. | 20 | $525 |
| Johnson & Johnson | 9 | $366 |
| Supernus Pharmaceuticals, Inc. | 12 | $255 |
| Axsome Therapeutics, Inc. | 15 | $248 |
| Collegium Pharmaceutical, Inc. | 14 | $216 |
| Idorsia Pharmaceuticals US Inc | 8 | $160 |
| Ironshore Pharmaceuticals Inc. | 6 | $131 |
| Almatica Pharma LLC | 6 | $106 |
| Lundbeck LLC | 3 | $53 |
| Tris Pharma Inc | 2 | $48 |
| Corium, LLC | 3 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Neuronetics, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,334
- VRAYLAR$805
- CAPLYTA$476
- ARISTADA$428
- REXULTI$224
- INVEGA SUSTENNA$223
- INVEGA TRINZA$223
- Fanapt$114
- ARISTADA INITIO$107
How this compares
$7,773 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 19 | $29,682 |
| Paroxetine ErParoxetine Hcl | 14 | $460 |
| Prazosin Hcl | 13 | $234 |
| Buspirone Hcl | 15 | $157 |
| Lorazepam | 14 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,739 | $29,68219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Monaca
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.